The importance of aligning cost control with clinical appropriateness and continuity of care.
Ryan Czado
Advertisement
Is the chief pharmacy officer at RazorMetrics, with more than 10 years of leadership experience across pharmacy benefit management, consulting, and employer-payer strategy. Previously, with Express Scripts, Deloitte, and Minuteman Health, Czado most recently oversaw pharmacy-practice growth at Lockton Companies, where he led revenue expansion for 250+ clients.
Articles by Ryan Czado
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Caplyta for Prevention of Schizophrenia in Adults
2
Eli Lilly Enters $ 2.3 Billion Agreement to Acquire Ajax Therapeutics
3
How Can Pharma Prices be Reduced for Americans Without Impacting Innovation?
4
Moving Cell and Gene Therapy Towards the Future: Q&A with Maher Masoud
5